Autoimmune osteomalacia: a novel FGF23-related hypophosphatemic osteomalacia

Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429–435

Article  CAS  PubMed  Google Scholar 

Hidaka N, Koga M, Kimura S, Hoshino Y, Kato H, Kinoshita Y, Makita N, Nangaku M, Horiguchi K, Furukawa Y, Ohnaka K, Inagaki K, Nakagawa A, Suzuki A, Takeuchi Y, Fukumoto S, Nakatani F, Ito N (2022) Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced osteomalacia: outcome of a retrospective surveillance. J Bone Miner Res 37:1479–1488

Article  CAS  PubMed  Google Scholar 

Kato H, Koga M, Kinoshita Y, Hidaka N, Hoshino Y, Takashi Y, Arai M, Kobayashi H, Katsura M, Nakamoto Y, Makise N, Ushiku T, Hoshi K, Nangaku M, Makita N, Fukumoto S, Ito N (2022) Utility of multimodality approach including systemic FGF23 venous sampling in localizing phosphaturic mesenchymal tumors. J Endocr Soc 7:bvac181

Article  PubMed  PubMed Central  Google Scholar 

Chong WH, Andreopoulou P, Chen CC, Reynolds J, Guthrie L, Kelly M, Gafni RI, Bhattacharyya N, Boyce AM, El-Maouche D, Crespo DO, Sherry R, Chang R, Wodajo FM, Kletter GB, Dwyer A, Collins MT (2013) Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res 28:1386–1398

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang Y, Hou G, Cheng W (2020) Performance of 68Ga-DOTA-SST PET/CT, octreoscan SPECT/CT and 18F-FDG PET/CT in the detection of culprit tumors causing osteomalacia: a meta-analysis. Nucl Med Commun 41:370–376

Article  CAS  PubMed  PubMed Central  Google Scholar 

El-Maouche D, Sadowski SM, Papadakis GZ, Guthrie L, Cottle-Delisle C, Merkel R, Millo C, Chen CC, Kebebew E, Collins MT (2016) (68)Ga-DOTATATE for tumor localization in tumor-induced osteomalacia. J Clin Endocrinol Metab 101:3575–3581

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoshino Y, Okamoto K, Ogawa T, Kato H, Irie K, Watanabe S, Kimura S, Hidaka N, Kinoshita Y, Kobayashi H, Hagiwara D, Kogawa M, Takayanagi H, Tanaka S, Nangaku M, Makita N, Burbelo PD, Saito T, Ito N (2025) Acquired osteomalacia associated with autoantibodies against PHEX. N Engl J Med 392:513–515

Article  PubMed  PubMed Central  Google Scholar 

Hartley IRIS, Roszko KL, Gafni RI, Futran J, Galisteo R, Bonilla FT, Samuel K, Burbelo P, Ferreira CR (2025) (SUN-572) PHEX Autoantibodies in idiopathic FGF23-mediated hypophosphatemia. Seattle, Washington

Google Scholar 

Shimazaki S, Kazukawa I, Yamammoto H, Mori K, Kihara M, Naruke Y, Minagawa M (2022) Elevation of serum fibroblast growth factor 23 level in a pediatric patient with lupus nephritis. CEN Case Rep 11:50–54

Article  PubMed  Google Scholar 

Kawaguchi T, Inamo Y (2023) Inappropriate secretion of fibroblast growth factor 23 despite hypophosphataemia with changes in bone turnover markers in a girl with systemic lupus erythematosus: case report and review of the literature. Mod Rheumatol Case Rep 7:60–64

Article  PubMed  Google Scholar 

Tabei Y, Ohtsu Y, Shimada M, Wada A, Hamajima E, Osawa Y, Takizawa T (2024) FGF23-related hypophosphatemic rickets preceding the onset of systemic lupus erythematosus: a juvenile case. Clin Case Rep 12:e8420

Article  PubMed  PubMed Central  Google Scholar 

Parkes M, Cortes A, van Heel DA, Brown MA (2013) Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet 14:661–673

Article  CAS  PubMed  Google Scholar 

Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC (2012) SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res 40:W452-457

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N (1997) Positional cloning of the APECED gene. Nat Genet 17:393–398

Article  CAS  PubMed  Google Scholar 

Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395–1401

Article  CAS  PubMed  Google Scholar 

Mathis D, Benoist C (2007) A decade of AIRE. Nat Rev Immunol 7:645–650

Article  CAS  PubMed  Google Scholar 

Bez P, Ceraudo M, Vianello F, Rattazzi M, Scarpa R (2024) Where AIRE we now? Where AIRE we going? Curr Opin Allergy Clin Immunol 24:448–456

Article  PubMed  PubMed Central  Google Scholar 

Cui X, Liu W, Jiang H, Zhao Q, Hu Y, Tang X, Liu X, Dai H, Rui H, Liu B (2025) IL-12 family cytokines and autoimmune diseases: a potential therapeutic target? J Transl Autoimmun 10:100263

Article  CAS  PubMed  Google Scholar 

Fierabracci A, Milillo A, Locatelli F, Fruci D (2012) The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: insights from genomic-wide association studies. Autoimmun Rev 12:281–288

Article  CAS  PubMed  Google Scholar 

Das T, Chen Z, Hendriks RW, Kool M (2018) A20/tumor necrosis factor α-induced protein 3 in immune cells controls development of autoinflammation and autoimmunity: lessons from mouse models. Front Immunol 9:104

Article  PubMed  PubMed Central  Google Scholar 

Stanford SM, Bottini N (2014) PTPN22: the archetypal non-HLA autoimmunity gene. Nat Rev Rheumatol 10:602–611

Article  CAS  PubMed  PubMed Central  Google Scholar 

Trombetti A, Al-Daghri N, Brandi ML, Cannata-Andía JB, Cavalier E, Chandran M, Chaussain C, Cipullo L, Cooper C, Haffner D, Harvengt P (2022) Interdisciplinary management of FGF23-related phosphate wasting syndromes: a consensus statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia. Nat Rev Endocrinol 18:366–384

Article  PubMed  Google Scholar 

Kato H, Koga M, Kinoshita Y, Taniguchi Y, Kobayashi H, Fukumoto S, Nangaku M, Makita N, Ito N (2021) Incidence of complications in 25 adult patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 106:e3682–e3692

Article  PubMed  Google Scholar 

Beck-Nielsen SS, Brusgaard K, Rasmussen LM, Brixen K, Brock-Jacobsen B, Poulsen MR, Vestergaard P, Ralston SH, Albagha OM, Poulsen S, Haubek D, Gjørup H, Hintze H, Andersen MG, Heickendorff L, Hjelmborg J, Gram J (2010) Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 87:108–119

Article  CAS  PubMed  Google Scholar 

Kato H, Okawa R, Ogasawara T, Hoshino Y, Hidaka N, Koga M, Kinoshita Y, Kobayashi H, Taniguchi Y, Fukumoto S, Nangaku M, Makita N, Hoshi K, Nakano K, Ito N (2023) Effect of conventional treatment on dental complications and ectopic ossifications among 30 adults with XLH. J Clin Endocrinol Metab 108:1405–1414

Article  PubMed  Google Scholar 

Insogna KL, Briot K, Imel EA, Kamenický P, Ruppe MD, Portale AA, Weber T (2018) A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis. J Bone Miner Res 33:1383–1393

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif